Glycans are sugar-based molecules that coat virtually every cell in your body and participate in nearly every biological process, from immune defense to cellular communication to organ development. Along with DNA, proteins, and lipids, glycans are one of the four fundamental classes of molecules that make up all living systems. They are built from a small set of simple sugar units linked together in branching chains, and they attach to proteins, fats, and even RNA to form complex structures called glycoconjugates. Despite being less famous than DNA or proteins, glycans arguably carry more raw information per unit than either, and their disruption is implicated in cancer, autoimmune disease, viral infection, and aging.
How Glycans Are Built
Your cells construct glycans by linking individual sugar units together through chemical bonds. A cell can synthesize thousands of unique glycan structures from a surprisingly small toolkit of simple sugars. The process starts in a compartment called the endoplasmic reticulum, where the first sugars get attached to a protein or lipid backbone. The real complexity develops in the Golgi apparatus, a separate compartment studded with specialized enzymes arranged in a specific order from one end to the other, like stations on an assembly line. As a protein moves through the Golgi, different enzymes add, trim, and modify the sugar chains in sequence.1PubMed Central. Golgi glycosylation The whole operation depends not just on having the right enzymes but on the physical organization of the factory itself. Disruptions to the Golgi’s structure can compromise the fidelity of glycan assembly.2PubMed Central. Glycosylation Quality Control by the Golgi Structure
Unlike DNA and proteins, glycans are not directly encoded by a template. Your genome doesn’t contain a blueprint for each glycan the way it contains a blueprint for each protein. Instead, glycan structures emerge from the combined activity of dozens of enzymes, the availability of sugar building blocks, and the local conditions inside the cell. This makes glycans inherently more variable and harder to predict than proteins, which is partly why the field of glycobiology has lagged behind genomics and proteomics.
The Sugar Code and Information Density
One of the most striking things about glycans is how much structural variety they can generate. When you compare the theoretical number of distinct molecules that can be assembled from a set of building blocks, sugars blow amino acids and nucleotides out of the water. Six sugar units linked together can produce more than seven orders of magnitude more possible structures than a six-unit peptide chain.3PubMed. Biological information transfer beyond the genetic code: the sugar code This extraordinary diversity arises because sugars can branch, link at multiple positions, and exist in different three-dimensional shapes, whereas amino acids and nucleotides are confined to linear chains.
Researchers sometimes call this the “sugar code” or the “third alphabet of life,” after nucleotides and amino acids. The enzymatic machinery for building sugar chains can link monosaccharides in ways that reach an unmatched number of distinct structures.4PubMed. The sugar code: Why glycans are so important This information density is not just theoretical. Cells exploit it constantly, decorating their surfaces with specific glycan patterns that serve as identity tags, docking signals, and molecular passwords. The practical consequence is that even subtle changes to a glycan’s structure can profoundly alter how a cell interacts with its neighbors, with immune cells, and with pathogens.
Two Major Flavors of Glycan Attachment
When glycans attach to proteins, they do so in two main ways. N-linked glycans connect to the protein through an asparagine amino acid, and O-linked glycans connect through a serine or threonine. The two types follow different assembly routes and serve overlapping but partly distinct functions. Some of the terminal sugar structures found on O-linked glycans are identical to those on N-linked glycans, and the enzymes that build these terminal structures may be shared between the two pathways.5Introduction to Glycobiology. O-Linked glycosylation This overlap suggests that both types evolved to participate in similar recognition events. But O-linked glycans have also evolved to fill unique roles, many of which scientists are still working to understand.
Beyond protein-linked glycans, sugars also attach to lipids (forming glycolipids) and even to RNA (forming glycoRNAs), a discovery that surprised the field when it emerged in recent years. The sheer range of molecules that carry glycan modifications helps explain why disruptions to glycosylation tend to produce widespread, multi-system effects rather than isolated problems.
Glycans and the Immune System
Your immune system is deeply entangled with glycans. Antibodies, the Y-shaped proteins that target invaders, carry a glycan attached to their stem region. The specific structure of that glycan dramatically affects what the antibody does once it binds its target. Variations in the sugar chain contribute significantly to the functional range of antibodies.6PubMed Central. Antibody glycosylation in inflammation, disease and vaccination For example, research has shown that the presence or absence of a single sugar called fucose on the antibody’s core glycan has a large effect on how well the antibody triggers the killing of target cells. When fucose is present, antibody-dependent cellular cytotoxicity drops substantially. Adding a different sugar, sialic acid, to the tip of the glycan can push the antibody toward anti-inflammatory behavior, but this effect depends on whether fucose is also present.7PubMed Central. Modulating IgG effector function by Fc glycan engineering
Glycan-modified antibodies (specifically IgG) are also central to managing the balance between inflammation and immune tolerance. Shifts in IgG glycosylation patterns are linked to the progression of inflammatory disorders.8PubMed Central. Immunoglobulin G N-Glycosylation and Inflammatory Factors: Analysis of Biomarkers for the Diagnosis of Moyamoya Disease This is not an abstract concern. When pharmaceutical companies manufacture therapeutic antibodies, they have to carefully control glycosylation to ensure the drug does what it’s supposed to and doesn’t trigger the wrong immune response.
Blood Types Are Glycans
Your ABO blood type, one of the most familiar facts in medicine, is determined by glycans. The A, B, and O designations refer to specific sugar structures displayed on the surface of your red blood cells. The enzymes that build these sugars are among the most common enzyme variants in the human population. These carbohydrate blood groups affect fundamental areas of clinical medicine, including infection risk, bleeding risk, transfusion compatibility, and organ transplantation outcomes.9PubMed Central. ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies The fact that one of the most medically consequential traits in human biology is, at its core, a glycan story gives some sense of how central sugar chemistry is to health.
How Viruses Exploit Glycans
Viruses have evolved to use glycans as doorways into cells. Influenza A viruses, for instance, bind to sialic acid, a sugar that sits at the tips of glycans on the surface of cells in your respiratory tract. The virus’s hemagglutinin protein grabs onto sialic acid as an attachment point, which then triggers entry into the cell.10PubMed Central. Cell binding, uptake, and infection of influenza A virus using recombinant antibody-based receptors The details of this interaction matter enormously for public health. Human flu viruses preferentially bind one type of sialic acid linkage, while bird flu viruses prefer another. But the specificity isn’t just about that single bond. The length of the sialylated glycan chain, the linkages deeper in the chain, and even modifications like fucosylation all affect how well a given flu strain can bind, which indirectly shapes whether a virus can jump between species.11PubMed Central. Influence of Host Sialic Acid Receptors Structure on the Host Specificity of Influenza Viruses
Viruses also use glycans defensively. Many enveloped viruses cloak their surface proteins in a thick coat of sugars that hides vulnerable spots from antibodies. Hepatitis C virus is a well-studied example: its glycan shield reduces the ability of the immune system to recognize and neutralize its envelope proteins.12PubMed Central. The hepatitis C virus glycan shield and evasion of the humoral immune response Interestingly, not all glycan shields are equally effective. An analysis of SARS and MERS coronaviruses found that despite extensive glycan decoration on their spike proteins, the shield was heterogeneously distributed and did not form the kind of dense, uniform coverage seen on some other viruses. The glycan shield on these coronaviruses was less effective at blocking immune recognition than might be expected.13PubMed Central. Vulnerabilities in coronavirus glycan shields despite extensive glycosylation Understanding these shields has direct implications for vaccine design, because knowing where the gaps are helps researchers identify which parts of a virus are most vulnerable to antibodies.
Glycans in Cancer
Cancer cells remodel their surface glycans in ways that help them survive and spread. One of the most consistent changes is hypersialylation, a general increase in sialic acid on the cell surface. During malignant transformation, the enzymes that add and remove sialic acids shift their expression levels, leading to an overcoating of sialylated glycans on tumor cells.14PubMed. Sialic acids in cancer biology and immunity This extra sialic acid acts like a molecular disguise. Immune cells carry receptors called Siglecs that bind sialic acid and, when engaged, receive “don’t attack” signals. Tumor cells exploit this system by displaying more sialic acid than healthy tissue, effectively telling immune cells to stand down.15Glycobiology. Targeting sialic acid–Siglec interactions to reverse immune suppression in cancer Researchers have described this as a “cloak” that helps tumor cells evade immunological surveillance, and disrupting this cloak is an active area of cancer immunotherapy research.16PubMed Central. Sialylation: A Cloak for Tumors to Trick the Immune System in the Microenvironment
Because glycan changes occur early in cancer development, they hold promise as biomarkers for early detection. Identifying shifts in glycosylation patterns at early disease stages could help guide treatment decisions, since early intervention greatly improves survival.17PubMed Central. Glycans and glycoproteins as specific biomarkers for cancer In many cancers, altered fucosylation and sialylation are consistently observed, making these patterns attractive targets for improved diagnostic tools.18PubMed. Glycans as cancer biomarkers
Human Milk Oligosaccharides and the Infant Gut
Breast milk is loaded with glycans, and their purpose is not to feed the baby directly. Human milk oligosaccharides (HMOs) are the third most abundant solid component of breast milk, after fat and lactose. Infants cannot digest them. Instead, HMOs travel intact to the lower intestines, where they serve as food for specific beneficial gut bacteria.19PubMed Central. Untangling human milk oligosaccharides and infant gut microbiome Breast milk appears to have been evolutionarily structured to shape the developing infant microbiome, and the specific HMO profile varies between mothers, which means different babies get different microbial “starter kits.”20PubMed. Human milk oligosaccharides and the infant gut microbiome from an eco-evolutionary perspective
Glycans also play a structural role in the gut lining throughout life. Mucins, the gel-forming proteins that make up the intestinal mucus barrier, are heavily decorated with O-linked glycans. These sugar coatings influence which microbes can colonize the mucus layer and how resistant the barrier is to degradation. When mucin glycosylation is altered, the barrier can become leaky, changing intestinal permeability and shifting the balance between helpful and harmful microbes.21PubMed. The role of mucin O-glycans in microbiota dysbiosis, intestinal homeostasis, and host-pathogen interactions
Glycans as a Biological Aging Clock
One of the more unexpected findings in glycobiology is that glycan patterns change with age in a highly predictable way. By analyzing IgG glycosylation in over 5,000 individuals across four European populations, researchers found that several specific glycan structures on antibodies change considerably as people age. A combination of just three glycans explained up to 58% of the variance in chronological age, substantially more than other aging biomarkers like telomere length. The remaining variance in those glycans correlated with physiological markers of biological age, suggesting IgG glycosylation reflects not just how old you are but how old your body acts.22PubMed Central. Glycans are a novel biomarker of chronological and biological ages
This work led to the development of a “glycan clock of age,” a biological aging biomarker based on IgG glycan composition. What makes it particularly intriguing is that multiple studies have shown the glycan clock can be partially reversed with lifestyle interventions, making it one of the few aging clocks that appears responsive to behavioral changes.23PubMed Central. Heritability of the glycan clock of biological age The underlying idea is that the glycan shifts reflect chronic low-grade inflammation associated with aging, and anything that reduces that inflammation may reset the clock to some degree.
When Glycosylation Goes Wrong From Birth
Congenital disorders of glycosylation (CDGs) are a group of more than 130 genetic diseases caused by defects in the enzymes and pathways that build and modify glycans. Most are inherited in a recessive pattern and tend to affect multiple organ systems, commonly causing growth failure, developmental delays, distinctive facial features, and abnormalities in blood clotting and hormone signaling.24PubMed Central. Congenital disorders of glycosylation Some CDGs also affect the brain and muscles simultaneously. At least 19 glycosylation-related genes, when mutated, can cause congenital muscular dystrophies that produce distinctive patterns of brain malformation alongside neuromuscular dysfunction.25Congenital Dystrophies – Neuromuscular Disorders Precision Medicine: Genomics to Care and Cure. Brain Features Distinguishing Congenital Disorders of Glycosylation
CDGs are individually rare but collectively illustrate a crucial point: glycosylation is not optional. When the machinery breaks down, the effects cascade through nearly every tissue and organ. These disorders are often underdiagnosed because their symptoms overlap with many other conditions, and testing for glycosylation defects hasn’t been part of standard clinical workups until relatively recently.
Red Meat, Neu5Gc, and an Evolutionary Wrinkle
Humans carry a peculiar evolutionary distinction among mammals. We lost the ability to produce a specific type of sialic acid called Neu5Gc due to a gene mutation that occurred millions of years ago. Most other mammals still make it. Because Neu5Gc is abundant in red meat, eating it introduces a foreign sugar into our bodies. This sugar gets metabolically incorporated into human tissues despite being recognized as foreign by the immune system, which produces anti-Neu5Gc antibodies against it.26PubMed. Potential deleterious role of anti-Neu5Gc antibodies in xenotransplantation
In a mouse model engineered to lack Neu5Gc production (mimicking the human condition), animals fed bioavailable Neu5Gc and challenged with anti-Neu5Gc antibodies developed systemic inflammation. When these mice were also prone to liver tumors, the combination of dietary Neu5Gc and anti-Neu5Gc antibodies dramatically increased the incidence of liver cancer.27PubMed Central. A red meat-derived glycan promotes inflammation and cancer progression This provides one mechanistic explanation for the well-known epidemiological link between red meat consumption and certain cancers. The same dynamic is also relevant to xenotransplantation (using animal organs in humans) and to any medical product derived from animal tissues, since those products may carry Neu5Gc that the human immune system will react against.
Engineering Glycans for Better Drugs
The pharmaceutical industry has come to appreciate that controlling glycosylation is critical for manufacturing effective biologic drugs. Therapeutic antibodies, which represent a multi-billion-dollar market, rely on specific glycan profiles to perform correctly. Adding or removing particular sugars on the antibody’s Fc region can boost cancer-killing activity, reduce unwanted inflammation, or extend the drug’s lifespan in the body.28PubMed Central. Glycoengineering of Therapeutic Antibodies with Small Molecule Inhibitors Glycoengineering, the deliberate manipulation of these sugar structures, is now a standard part of antibody drug development.29PubMed Central. Combinatory glycoengineering of monoclonal antibodies and its application in cancer therapy: a narrative review
A related frontier involves using chemoenzymatic methods to produce antibodies with perfectly uniform glycan profiles, which would give tighter control over drug behavior. So far, though, these successes have been mostly limited to small-scale lab work, and scaling them to industrial production remains a significant challenge.30Frontiers in Catalysis. Challenges and Opportunities for the Large-Scale Chemoenzymatic Glycoengineering of Therapeutic N-Glycosylated Monoclonal Antibodies
Why Glycobiology Has Lagged Behind Genomics
Given how central glycans are to health and disease, it’s fair to ask why you’ve probably heard far more about DNA and proteins. Part of the answer is technical. Glycans are structurally more complex and harder to analyze than linear molecules like DNA. They branch, they exist in multiple three-dimensional conformations, and they aren’t encoded by a readable template. For decades, the analytical tools simply weren’t powerful enough to handle this complexity. Mass spectrometry has become the enabling technology in glycomics, and advances in separation techniques like hydrophilic interaction chromatography have pushed detection limits down to roughly one femtomole of an oligosaccharide.31PubMed. Structural glycomics using hydrophilic interaction chromatography (HILIC) with mass spectrometry Glycan microarray technology, which can screen how glycan-binding proteins interact with hundreds of sugar structures simultaneously, has also opened up insights into how glycans function in signaling and pathogen recognition.32PubMed Central. The challenge and promise of glycomics
New tools for studying glycans in living systems are also emerging. Metabolic oligosaccharide engineering (MOE) allows researchers to feed cells unnatural sugar analogs that get incorporated into glycans, tagging them with chemical handles that can be detected with fluorescent dyes or other probes. This approach has been used to image glycan production in developing zebrafish embryos, distinguishing newly made glycans from older ones in real time.33Cell Chemical Biology. What Are Glycans and Why Are They Important? – Section: Metabolic Oligosaccharide Engineering More recently, selenium-based probes have been developed that allow quantitative glycan detection with higher sensitivity and lower background noise than earlier methods.34Nature Communications. Selenium-based metabolic oligosaccharide engineering strategy for quantitative glycan detection These tools are closing the gap between glycobiology and the better-funded, better-equipped worlds of genomics and proteomics, and the pace of discovery has accelerated considerably in the past decade.
Glycans Beyond Animal Cells
Glycans are not just an animal phenomenon. Plant cell walls are built from polysaccharides like cellulose, hemicellulose, and pectin, which are themselves glycan polymers. These plant glycans define the mechanical strength, flexibility, and chemical properties of plant tissues.35Cellulose. On the structure, conformation and reactivity of β-1,4-linked plant cell wall glycans: why are xylan polysaccharides or furanosyl substituents easier to hydrolyze than cellulose? The difficulty of breaking down cellulose compared to other plant wall glycans is, in fact, a central question in biofuel research and industrial chemistry. Fungi, bacteria, and archaea also use glycans extensively, both as structural components and as tools for interacting with their environments. The ubiquity of glycans across all domains of life underscores that sugar-based biology is not a niche specialization but one of the oldest and most fundamental molecular strategies on the planet.